Industry News | 文章中心 | Nanjing Bike Biotechnology Co., Ltd

Development of peptides and their difficulties in formulation

2024-04-09

本文摘自——药精通Bio
Save innovative drugs, can not be delayed

2024-04-08

本文摘自——药精通Bio
Pharmaceutical companies to build the API base of the tuyere has been closed

2024-04-07

本文摘自——药融圈
Peptide drugs that will hit the line in 2024

2024-04-03

本文摘自——药精通Bio
Kyverna: Publish the results of the first application of autoimmune CAR-T therapy in MS patients

2024-04-02

本文摘自——药融圈
The past history of the first ophthalmic gene therapy drug

2024-04-01

本文摘自——药精通Bio

Pre 28 29 30 31 32 33 34 35 36 37 Next 37Pages

Contact Us

Add：1st Floor, Building 9, No. 6 Qiande Road, Jiangning District, Nanjing

PE：211100

Wet：www.bicbiotech.com

Email：sales@bicbiotech.com

Sales Department

TEL：86-025-58906079

Copyright © 2023 Nanjing Bic Biotechnology Co., Ltd SU ICP:2024061905-1

Technical:www.nj-gm.com

Consultation with online customer service

Service hotline

025-58906079
18066052887

功能和特性

价格和优惠

获取内部资料